Macnaughtan, Jane

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Mookerjee, R. P., Pavesi, M., Thomsen, K. L., Mehta, G., Macnaughtan, J., Bendtsen, F., Coenraad, M., Sperl, J., Gines, P., Moreau, R., et al. (2016) · Journal of Hepatology

Liver Disease and TransplantationSepsis Diagnosis and Treatment

Cited by 248

Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure

Engelmann, C., Sheikh, M., Sharma, S., Kondo, T., Loeffler-Wirth, H., Zheng, Y. B., Novelli, S., Hall, A., Kerbert, A. J. C., Macnaughtan, J., et al. (2020) · Journal of Hepatology

Liver Disease and TransplantationImmune Response and Inflammation

Cited by 174

Beyond scoring: a modern interpretation of disease progression in chronic liver disease

Rosselli, M., MacNaughtan, J., Jalan, R., & Pinzani, M. (2013) · Gut

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 96

The gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance

Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2021) · Annals of Medicine

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 81

α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study

Hurley, M. J., Menozzi, E., Koletsi, S., Bates, R., Gegg, M. E., Chau, K.-Y., Blottière, H. M., Macnaughtan, J., & Schapira, A. H. V. (2023) · Brain Communications

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 22